Immucell Corp
(NASDAQ: ICCC)
| Exchange: | NASDAQ |
| Stock: | ImmuCell Corporation |
| Industry: | Diagnostic Substances |
| Employees: | 25 |
| ImmuCell Corporation creates scientifically proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. The Company’s product, First Defense, is manufactured from cows’ colostrum using the Company's vaccine and whey protein purification technologies. The target disease, bovine enteritis (calf scours), causes diarrhea and dehydration in newborn calves and often leads to serious sickness and even death. First Defense is the only USDA-licensed, orally delivered scours preventive product on the market for calves with claims against E. coli K99 and coronavirus (two causes of scours). First Defense provides bovine antibodies that newborn calves need. Wipe Out Dairy Wipes consist of biodegradable towelettes that are pre-moistened with a Nisin to prepare the teat area of a cow in advance of milking. |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
